Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2012-03-30 01:30Bayer Extends and Expands Partnership with Tsinghua University and more...
2012-03-29 01:30Roche Cuts the Price of Cancer Drugs in India - Under Pressure? and more...
2012-03-28 01:30Lee's Pharma to Obtain China Rights for 3 Drugs from Regenerex and more...
2012-03-27 01:30Chongqing Huapont to Raise $146 Million in Private Placement
2012-03-25 01:30The Week in Review: China Pharma -- From Local to Global
2012-03-24 01:30Anaphore of San Diego Buys RuiYi, a Shanghai Drug Developer and more...
2012-03-23 01:30Qiagen to Partner with Shanghai Jiao Tong University Lab
2012-03-22 01:30Lilly Wants to Double China Revenues; Seeks Distribution Partners and more...
2012-03-21 01:30ChinaBioÔö£éÔö¼?½ White Paper - China Life Science: From Local to Global
2012-03-20 01:30Sihuan Pharma Doubled its Revenue in 2011 and more...
2012-03-18 01:30The Week in Review: OriGene Technologies Acquires Zhongshan Biotech
2012-03-17 01:30Hisun Pharma Diversifies into Animal Health with New Partnership and more...
2012-03-16 01:30China's Pressure on Drug Prices May Hurt Outlook for Pharma and more...
2012-03-15 01:30Bayer Seeks $3.3 Billion of China Revenues by 2015
2012-03-14 01:30Boehringer Ingelheim Plans Shanghai Animal Vaccine R&D Center and more...
2012-03-13 01:30China to Set Up Global Clinical Trial Center in Tianjin and more...
2012-03-11 01:30The Week in Review: Abcam Pays $170 Million for China-Connected Epitomics
2012-03-10 01:30China Ups Science Budget for 2012 and more...
2012-03-09 01:30For Roche, China Is Necessary and more...
2012-03-08 01:30Aslan Pharma Selects PharmaNet/i3 as Clinical Trial Partner and more...
2012-03-07 01:30Abcam Buys Epitomics for $170 Million and more...
2012-03-06 01:30Wuhan Kindstar Diagnostics Raises $20 Million for Testing Services and more...
2012-03-04 01:30The Week in Review: Shaanxi Bicon Pharma Raises $250 Million
2012-03-03 01:30MBK Partners Sells Luye Pharma Stake to Fellow PE Funds
2012-03-02 01:30Yiling Pharma to Spend $22 Million on Three Drug Collaborations
2012-03-01 01:30C3 Jian, a US Dental Company with China Connections, Raises $30 Million and more...

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC